Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

TY - JOUR

T1 - Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

AU - Martin, Paul

AU - Brown, Nik

AU - Turner, Andrew

PY - 2008/6

Y1 - 2008/6

N2 - The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented "regime of hope". This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a "promissory bioeconomy".

AB - The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented "regime of hope". This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a "promissory bioeconomy".

KW - stem cells

KW - cord blood banking

KW - expectations

KW - bioeconomy

KW - TRANSPLANTATION

UR - http://www.scopus.com/inward/record.url?scp=45849095761&partnerID=8YFLogxK

U2 - 10.1080/14636770802077074

DO - 10.1080/14636770802077074

M3 - Article

SN - 1463-6778

VL - 27

SP - 127

EP - 143

JO - New Genetics and Society

JF - New Genetics and Society

IS - 2

ER -